|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-2-23
|
|
pubmed:abstractText |
Aspirin is widely used as a preventive measure against occlusive vascular diseases. Since the age group in which aspirin use has become prevalent is similar to the one presenting with prostate cancer, we decided to examine the potential effects of aspirin on prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2000 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
172-80
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10639187-Antineoplastic Agents,
pubmed-meshheading:10639187-Aspirin,
pubmed-meshheading:10639187-Cell Division,
pubmed-meshheading:10639187-Dose-Response Relationship, Drug,
pubmed-meshheading:10639187-Doxorubicin,
pubmed-meshheading:10639187-Drug Resistance, Neoplasm,
pubmed-meshheading:10639187-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:10639187-Humans,
pubmed-meshheading:10639187-Male,
pubmed-meshheading:10639187-P-Glycoprotein,
pubmed-meshheading:10639187-Platelet Aggregation Inhibitors,
pubmed-meshheading:10639187-Prostatic Neoplasms,
pubmed-meshheading:10639187-Tumor Cells, Cultured
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Contrasting effects of aspirin on prostate cancer cells: suppression of proliferation and induction of drug resistance .
|
|
pubmed:affiliation |
Department of Human Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
